Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henrik Green

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Pigment Cell Research|July 16, 2003
Melanin inhibits cytotoxic effects of doxorubicin and daunorubicin in MOLT 4 cellsSamuel P S Svensson, Sofi Lindgren, Wendy Powell, et al.
Forensic Science International|November 7, 2020
In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT<sub>1A</sub>, and 5-HT<sub>2A</sub> receptors-On-target receptor potency and efficacy, and off-target effectsAnna Åstrand, Davide Guerrieri, Svante Vikingsson, et al.
Metabolites|February 25, 2022
Postmortem Metabolomics Reveal Acylcarnitines as Potential Biomarkers for Fatal Oxycodone-Related IntoxicationAlbert Elmsjö, Carl Söderberg, Gerd Jakobsson, et al.
The Journal of Clinical Psychiatry|January 18, 2024
CYP2D6 Genotyping and Inhibition as Predictors of Adverse Drug Reactions in Depressive DisordersAmanda Holck, Marie Asp, Henrik Green, et al.
Drug Testing and Analysis|June 2, 2026
In Vitro Metabolism of Δ<sup>8</sup>-, Δ<sup>9</sup>-, and Δ<sup>10</sup>-THC in Human Hepatocytes: Distinct Δ<sup>10</sup>-THC Biotransformation and Implications for Drug TestingRobert Kronstrand, Henrik Green, Markus Loh, et al.
Chemical Research in Toxicology|April 23, 2021
Post-Mortem Metabolomics: A Novel Approach in Clinical Biomarker Discovery and a Potential Tool in Death InvestigationsAlbert Elmsjö, Svante Vikingsson, Carl Söderberg, et al.
BMC Cancer|January 10, 2019
Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancerHakon Blomstrand, Ursula Scheibling, Charlotte Bratthäll, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 2, 2023
Impact of resection margins and para-aortic lymph node metastases on recurrence patterns and prognosis in resectable pancreatic cancer - a long-term population-based cohort studyHakon Blomstrand, Hans Olsson, Henrik Green, et al.
Environmental Toxicology and Pharmacology|April 13, 2026
In vitro metabolomics for the characterization of drugs of abuse and new psychoactive substances in SH-SY5Y cellsManuela Carla Monti, Darta Stalberga, Henrik Green, et al.
Critical Reviews in Oncology/Hematology|April 13, 2025
Pharmacogenomics in pediatric oncology patients with solid tumors related to chemotherapy-induced toxicity: A systematic reviewPaula Hansson, Christopher Blacker, Hanna Uvdal, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Pigment Cell Research|July 16, 2003
Melanin inhibits cytotoxic effects of doxorubicin and daunorubicin in MOLT 4 cellsSamuel P S Svensson, Sofi Lindgren, Wendy Powell, et al.
Forensic Science International|November 7, 2020
In vitro characterization of new psychoactive substances at the μ-opioid, CB1, 5HT<sub>1A</sub>, and 5-HT<sub>2A</sub> receptors-On-target receptor potency and efficacy, and off-target effectsAnna Åstrand, Davide Guerrieri, Svante Vikingsson, et al.
Metabolites|February 25, 2022
Postmortem Metabolomics Reveal Acylcarnitines as Potential Biomarkers for Fatal Oxycodone-Related IntoxicationAlbert Elmsjö, Carl Söderberg, Gerd Jakobsson, et al.
The Journal of Clinical Psychiatry|January 18, 2024
CYP2D6 Genotyping and Inhibition as Predictors of Adverse Drug Reactions in Depressive DisordersAmanda Holck, Marie Asp, Henrik Green, et al.
Drug Testing and Analysis|June 2, 2026
In Vitro Metabolism of Δ<sup>8</sup>-, Δ<sup>9</sup>-, and Δ<sup>10</sup>-THC in Human Hepatocytes: Distinct Δ<sup>10</sup>-THC Biotransformation and Implications for Drug TestingRobert Kronstrand, Henrik Green, Markus Loh, et al.
Chemical Research in Toxicology|April 23, 2021
Post-Mortem Metabolomics: A Novel Approach in Clinical Biomarker Discovery and a Potential Tool in Death InvestigationsAlbert Elmsjö, Svante Vikingsson, Carl Söderberg, et al.
BMC Cancer|January 10, 2019
Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancerHakon Blomstrand, Ursula Scheibling, Charlotte Bratthäll, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 2, 2023
Impact of resection margins and para-aortic lymph node metastases on recurrence patterns and prognosis in resectable pancreatic cancer - a long-term population-based cohort studyHakon Blomstrand, Hans Olsson, Henrik Green, et al.
Environmental Toxicology and Pharmacology|April 13, 2026
In vitro metabolomics for the characterization of drugs of abuse and new psychoactive substances in SH-SY5Y cellsManuela Carla Monti, Darta Stalberga, Henrik Green, et al.
Critical Reviews in Oncology/Hematology|April 13, 2025
Pharmacogenomics in pediatric oncology patients with solid tumors related to chemotherapy-induced toxicity: A systematic reviewPaula Hansson, Christopher Blacker, Hanna Uvdal, et al.
Pageof 7